Skip to main content
. 2019 Mar 27;15(1):52–58. doi: 10.5114/aic.2019.83652

Figure 4.

Figure 4

A – Femoral and antecubital fossa vein adenosine administration for individual cases with the line of identity. B – Mean times to peak hyperemia with femoral and antecubital fossa vein adenosine infusion. C – Exemplary case of fractional flow reserve (FFR) assessment with femoral and antecubital fossa vein adenosine infusion